Methods and biomarkers for analysis of colorectal cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9822417
APP PUB NO 20140342361A1
SERIAL NO

14369872

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods and biomarkers (e.g., gene expression biomarkers) for detection of colorectal cancer in biological samples (e.g., tissue samples, biopsy samples, stool samples, blood samples, plasma samples, serum samples). In some embodiments, methods and biomarkers of the present invention find use in detection of colon cancer, providing a prognosis to colorectal cancer patients, and in companion diagnostics.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSLO UNIVERSITETSSYKEHUS HFP O BOX 4950 NYDALEN N-0424 OSLO N-0424

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Agesen, Trude Holmeide Oslo, NO 2 1
Lind, Guro Elisabeth Oslo, NO 5 3
Lothe, Ragnhild A Oslo, NO 12 9
Nesbakken, Arild Royken, NO 3 1
Skotheim, Rolf Inge Oslo, NO 5 3
Sveen, Anita Oslo, NO 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00